Esophageal And Gastric Cancer

More documents

Recommendations

Info

One “Organ System”, Three <strong>Cancer</strong>s • 35,000 cases/yr • 25,000 deaths/yr • Three distinct pathologic entities – Squamous cell carcinoma of the esophagus – Adenocarcinoma of the distal esophagus and junction with stomach (“GE junction”) – Adenocarcinoma of the distal stomach
Page 1: Esophageal and Gastric Cancer: Upda
Page 5 and 6: Staging of Esophageal Cancer •TNM
Page 7 and 8: Esophageal Cancer: Treatment Approa
Page 9 and 10: Neoadjuvant Chemotherapy of Esophag
Page 11 and 12: March 1 2008 Small new study in sup
Page 13 and 14: Trimodality Trial (CALGB 9781) medi
Page 15 and 16: Preoperative Chemoradiation of Esop
Page 17 and 18: RTOG 8501: Survival Survival % 100
Page 19 and 20: Treatment of Advanced Esophageal Ca
Page 21 and 22: Esophageal Stent Placement Lesion p
Page 23 and 24: Adenocarcinoma of the Esophagus: On
Page 25 and 26: Gastric Cancer: Worldwide incidence
Page 27 and 28: Gastric Cancer Treatment in the 21
Page 29 and 30: The “MAGIC” Trial: Neo/Adjuvant
Page 31 and 32: JCO Feb 20, 2009 • Higher chance
Page 33 and 34: Adjuvant Chemoradiation Therapy for
Page 35 and 36: The Role of Chemotherapy in Advance
Page 37 and 38: Early Phase Studies of Taxotere in
Page 39 and 40: More tolerable treatment options Ja
Page 41 and 42: Oxaliplatin has reduced toxicity co
Page 43 and 44: Oxaliplatin • Progression free su
Page 45 and 46: Biologic Agents: Possible Treatment
Page 47 and 48: Hot off the press - GI ASCO January
Page 49 and 50: ChemoRT plus Erbitux • Complete p

Esophageal And Gastric Cancer

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?